6.
Fujihata S, Ogawa R, Nakaya S, Hayakawa S, Okubo T, Sagawa H
. The impact of skeletal muscle wasting during neoadjuvant chemotherapy on postoperative anastomotic leakage in patients with esophageal cancer. Esophagus. 2020; 18(2):258-266.
DOI: 10.1007/s10388-020-00774-1.
View
7.
Reisinger K, Bosmans J, Uittenbogaart M, Alsoumali A, Poeze M, Sosef M
. Loss of Skeletal Muscle Mass During Neoadjuvant Chemoradiotherapy Predicts Postoperative Mortality in Esophageal Cancer Surgery. Ann Surg Oncol. 2015; 22(13):4445-52.
PMC: 4644199.
DOI: 10.1245/s10434-015-4558-4.
View
8.
Tukanova K, Chidambaram S, Guidozzi N, Hanna G, McGregor A, Markar S
. Physiotherapy Regimens in Esophagectomy and Gastrectomy: a Systematic Review and Meta-Analysis. Ann Surg Oncol. 2021; 29(5):3148-3167.
PMC: 8990957.
DOI: 10.1245/s10434-021-11122-7.
View
9.
Christensen J, Simonsen C, Banck-Petersen A, Thorsen-Streit S, Herrstedt A, Djurhuus S
. Safety and feasibility of preoperative exercise training during neoadjuvant treatment before surgery for adenocarcinoma of the gastro-oesophageal junction. BJS Open. 2019; 3(1):74-84.
PMC: 6354184.
DOI: 10.1002/bjs5.50110.
View
10.
Halliday L, Doganay E, Wynter-Blyth V, Hanna G, Moorthy K
. The Impact of Prehabilitation on Post-operative Outcomes in Oesophageal Cancer Surgery: a Propensity Score Matched Comparison. J Gastrointest Surg. 2020; 25(11):2733-2741.
PMC: 8602132.
DOI: 10.1007/s11605-020-04881-3.
View
11.
Low D, Allum W, De Manzoni G, Ferri L, Immanuel A, Kuppusamy M
. Guidelines for Perioperative Care in Esophagectomy: Enhanced Recovery After Surgery (ERAS) Society Recommendations. World J Surg. 2018; 43(2):299-330.
DOI: 10.1007/s00268-018-4786-4.
View
12.
Boden I, Skinner E, Browning L, Reeve J, Anderson L, Hill C
. Preoperative physiotherapy for the prevention of respiratory complications after upper abdominal surgery: pragmatic, double blinded, multicentre randomised controlled trial. BMJ. 2018; 360:j5916.
PMC: 5782401.
DOI: 10.1136/bmj.j5916.
View
13.
Inoue J, Ono R, Makiura D, Kashiwa-Motoyama M, Miura Y, Usami M
. Prevention of postoperative pulmonary complications through intensive preoperative respiratory rehabilitation in patients with esophageal cancer. Dis Esophagus. 2012; 26(1):68-74.
DOI: 10.1111/j.1442-2050.2012.01336.x.
View
14.
Zhong J, Zhang S, Li C, Hu Y, Wei W, Liu L
. Active cycle of breathing technique may reduce pulmonary complications after esophagectomy: A randomized clinical trial. Thorac Cancer. 2021; 13(1):76-83.
PMC: 8720618.
DOI: 10.1111/1759-7714.14227.
View
15.
Patel A, Friedenreich C, Moore S, Hayes S, Silver J, Campbell K
. American College of Sports Medicine Roundtable Report on Physical Activity, Sedentary Behavior, and Cancer Prevention and Control. Med Sci Sports Exerc. 2019; 51(11):2391-2402.
PMC: 6814265.
DOI: 10.1249/MSS.0000000000002117.
View
16.
Shaker R, Kern M, Bardan E, Taylor A, STEWART E, Hoffmann R
. Augmentation of deglutitive upper esophageal sphincter opening in the elderly by exercise. Am J Physiol. 1997; 272(6 Pt 1):G1518-22.
DOI: 10.1152/ajpgi.1997.272.6.G1518.
View
17.
Namiki C, Hara K, Tohara H, Kobayashi K, Chantaramanee A, Nakagawa K
. Tongue-pressure resistance training improves tongue and suprahyoid muscle functions simultaneously. Clin Interv Aging. 2019; 14:601-608.
PMC: 6432900.
DOI: 10.2147/CIA.S194808.
View
18.
Ramsey K, Rojer A, DAndrea L, Otten R, Heymans M, Trappenburg M
. The association of objectively measured physical activity and sedentary behavior with skeletal muscle strength and muscle power in older adults: A systematic review and meta-analysis. Ageing Res Rev. 2021; 67:101266.
DOI: 10.1016/j.arr.2021.101266.
View
19.
Klukowska A, Staartjes V, Vandertop W, Schroder M
. Five-Repetition Sit-to-Stand Test Performance in Healthy Individuals: Reference Values and Predictors From 2 Prospective Cohorts. Neurospine. 2022; 18(4):760-769.
PMC: 8752709.
DOI: 10.14245/ns.2142750.375.
View
20.
Kobayashi K, Kanetaka K, Yoneda A, Kobayashi S, Maruya Y, Isagawa Y
. Downstaging and Histological Effects Might Be Reliable Predictors of the Efficacy of DOC+CDDP+5-FU (DCF) as Neoadjuvant Therapy for Stage III or Borderline Resectable Esophageal Cancer: a Single Institute Experience. J Gastrointest Cancer. 2020; 52(2):582-592.
DOI: 10.1007/s12029-020-00431-x.
View